Cargando…

Clinical Presentations, Antiplatelet Strategies and Prognosis of Patients with Stent Thrombosis: An Observational Study of 140 Patients

BACKGROUND: Until now there has been scarce evidence regarding an optimal antiplatelet strategy and clinical outcomes for patients who had suffered from stent thrombosis (ST). METHODS AND RESULTS: 140 patients who suffered from stent thrombosis were prospectively registered. Patients received dual (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Ya-Ling, Zhang, Quan-Yu, Li, Yi, Guan, Shao-Yi, Jing, Quan-Min, Wang, Zu-Lu, Zhao, Xin, Wang, Xiao-Zeng, Ma, Ying-Yan, Wang, Bin, Deng, Jie, Wang, Geng, Kim, Young-Hak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485366/ https://www.ncbi.nlm.nih.gov/pubmed/23119044 http://dx.doi.org/10.1371/journal.pone.0048520

Ejemplares similares

Efficacy and safety of individually tailored antiplatelet therapy in patients with acute coronary syndrome after coronary stenting: a single center, randomized, feasibility study
por: Zhu, Hong-Chang, et al.
Publicado: (2015)

Subacute Stent Thrombosis in a Patient With COVID-19 Despite Adherence to Antiplatelets
por: Elkholy, Karim O, et al.
Publicado: (2021)

Dual Antiplatelet Therapy Over 6 Months Increases the Risk of Bleeding after Biodegradable Polymer-Coated Sirolimus Eluting Stents Implantation: Insights from the CREATE Study
por: ZHANG, LEI, et al.
Publicado: (2014)

Simultaneous Thrombosis of Two Drug-Eluting Stents After Discontinuation of Dual Antiplatelet Therapy for a Day
por: Chen, Hung Yi
Publicado: (2012)

Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice
por: Cho, Min Soo, et al.
Publicado: (2017)

Risk Factors for Coronary Drug-Eluting Stent Thrombosis: Influence of Procedural, Patient, Lesion, and Stent Related Factors and Dual Antiplatelet Therapy
por: Sudhir, Krishnankutty, et al.
Publicado: (2013)

Very Late Stent Thrombosis 42 Months after Implantation of Sirolimus-Eluting Stent and Discontinuation of Antiplatelet Therapy
por: Sibbing, Dirk, et al.
Publicado: (2009)

Case report: Late in-stent thrombosis in a patient with vertebrobasilar dolichoectasia after stent-assisted coil embolization due to the discontinuation of antiplatelet therapy
por: Ji, Zhe, et al.
Publicado: (2023)

Comparison of the Efficacy of Drug-eluting Stents Versus Bare-metal Stents for the Treatment of Left Main Coronary Artery Disease
por: Wang, Xiao-Zeng, et al.
Publicado: (2015)

Long-term follow-up study of elderly patients with covered stent implantation after coronary perforation
por: Wang, Geng, et al.
Publicado: (2014)

Coronary Stent Infection Presented as Recurrent Stent Thrombosis
por: Lai, Chih-Hung, et al.
Publicado: (2017)

The stent in the high-bleeding risk patient: antiplatelet monotherapy?
por: Capranzano, Piera
Publicado: (2022)

Duration of dual antiplatelet therapy in patients with acute coronary syndrome undergoing drug-eluting stent implantation: A meta-analysis
por: Geng, Xue, et al.
Publicado: (2020)

Early stent thrombosis. Aetiology, treatment, and prognosis
por: Tyczyński, Paweł, et al.
Publicado: (2014)

In-hospital prognosis of first-ever noncardiogenic ischemic stroke in patients with and without indication for prestroke antiplatelet therapy: Chinese Stroke Center Alliance
por: Xu, Yu-Yuan, et al.
Publicado: (2021)

Role of insulin-like growth factor 1 in stent thrombosis under effective dual antiplatelet therapy
por: Yalcin, Ahmet Arif, et al.
Publicado: (2014)

Perioperative management of antiplatelet therapy in patients with drug-eluting stents
por: Dimitrova, G, et al.
Publicado: (2012)

Very Late Thrombosis of a Drug-Eluting Stent After Discontinuation of Dual Antiplatelet Therapy in a Patient Treated With Both Drug-Eluting and Bare-Metal Stents
por: Kim, Sung Soo, et al.
Publicado: (2009)

In-stent thrombosis after 68 months of implantation inspite of continuous dual antiplatelet therapy: a case report
por: Nagrani, Tarun, et al.
Publicado: (2010)

What should be done when appropriate antiplatelet therapy fails to prevent stent thrombosis? Two case reports
por: Hong, Sungman, et al.
Publicado: (2023)

Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease
por: Kao, Chih-Chin, et al.
Publicado: (2021)

Very Late Stent Thrombosis after Discontinuation of Antiplatelet Agents during Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining after Implantation of a Second-generation Drug-eluting Stent
por: Endo, Akihiro, et al.
Publicado: (2021)

Antiplatelet resistance and the role of associated variables in stable patients treated with stenting
por: Uzun, Fatih, et al.
Publicado: (2015)

Prognosis and antiplatelet therapy of small single subcortical infarcts in penetrating artery territory: a post hoc analysis of the Third China National Stroke Registry
por: Xu, Yu-Yuan, et al.
Publicado: (2022)

The association of white matter hyperintensities with stroke outcomes and antiplatelet therapy in minor stroke patients
por: Xu, Yu-Yuan, et al.
Publicado: (2020)

Antiplatelet Therapy Improves the Prognosis of Patients with Hepatocellular Carcinoma
por: Hayashi, Tsuguru, et al.
Publicado: (2020)

The hypercoagulable profile of patients with stent thrombosis
por: Loeffen, R, et al.
Publicado: (2015)

TMEM140 is associated with the prognosis of glioma by promoting cell viability and invasion
por: Li, Bin, et al.
Publicado: (2015)

Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapy
por: Hobson, Alex R, et al.
Publicado: (2008)

Impact of early (3 months) dual antiplatelet treatment interruption prior to renal transplantation in patients with second-generation DES on perioperative stent thrombosis and MACEs
por: Doğan, Ali, et al.
Publicado: (2017)

Should antiplatelet therapy be interrupted in drug eluting stent recipients throughout the periendoscopic period? A very late stent thrombosis case report and review of the literature
por: Dong, Peng, et al.
Publicado: (2014)

Impact of Anemia and Dual Antiplatelet Therapy on Mortality in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents
por: Wang, Huili, et al.
Publicado: (2015)

Risk of Heart Failure in Patients with ST-Elevation Myocardial Infarction Receiving Drug-Eluting Stent Implantation and Undefined Duration of Antiplatelets
por: Chien, Li-Nien, et al.
Publicado: (2022)

Antiplatelet therapy in patients with coronary artery stents for noncardiac surgery: Role of thromboelastography
por: Jain, Rashmi, et al.
Publicado: (2011)

The safety of triple antiplatelet therapy under thromboelastography guidance in patients undergoing stenting for ischemic cerebrovascular disease
por: Wu, Zhonghua, et al.
Publicado: (2019)

Effectiveness of Two-Year versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis after Drug-Eluting Stent Implantation
por: Poorhosseini, Hamid Reza, et al.
Publicado: (2012)

Change of Platelet Reactivity to Antiplatelet Therapy after Stenting Procedure for Cerebral Artery Stenosis: VerifyNow Antiplatelet Assay before and after Stenting
por: Lee, Deok Hee, et al.
Publicado: (2012)

Erratum: TMEM140 is associated with the prognosis of glioma by promoting cell viability and invasion
por: Li, Bin, et al.
Publicado: (2015)

A Patient with Repeated Carotid Stent Thrombosis
por: Amin, Arash, et al.
Publicado: (2022)

Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial
por: Wang, David, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_46da406b5tt92vit8cffia7bh4